The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by ...
Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...
The Metastatic Breast Cancer Pipeline Report provides a disease overview, pipeline scenario, and therapeutic assessment of the key pipeline therapies in this domain. The Metastatic Breast Cancer ...
LONDON, Sept. 30, 2026 /PRNewswire/ -- Clarenta today announced that Leads To Development (L2D) has joined Clarenta Group ...
The Journal of Pharmaceutical Investigation has announced a special issue on translational advances in pharmaceutical dosage ...
The goal of this collaborative was to examine the contributing factors towards the failure of late-stage clinical product development and develop key considerations for stakeholders to improve the ...
The Journal of Pharmaceutical Investigation has announced a January 2027 special issue on translational advances in ...
By Sriparna Roy Sept 16 (Reuters) - Novartis has halted development of an experimental drug for amyotrophic lateral sclerosis after it failed to meet goals in a mid-stage study, marking the latest ...
Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Batten Disease - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Batten Disease - Pipeline Insight, 2025" report offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results